JP2018536686A5 - - Google Patents

Download PDF

Info

Publication number
JP2018536686A5
JP2018536686A5 JP2018530000A JP2018530000A JP2018536686A5 JP 2018536686 A5 JP2018536686 A5 JP 2018536686A5 JP 2018530000 A JP2018530000 A JP 2018530000A JP 2018530000 A JP2018530000 A JP 2018530000A JP 2018536686 A5 JP2018536686 A5 JP 2018536686A5
Authority
JP
Japan
Prior art keywords
oxo
thia
dihydro
carboxamide
triazaacenaphthylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018530000A
Other languages
English (en)
Japanese (ja)
Other versions
JP6835846B2 (ja
JP2018536686A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/065954 external-priority patent/WO2017100662A1/en
Publication of JP2018536686A publication Critical patent/JP2018536686A/ja
Publication of JP2018536686A5 publication Critical patent/JP2018536686A5/ja
Application granted granted Critical
Publication of JP6835846B2 publication Critical patent/JP6835846B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018530000A 2015-12-10 2016-12-09 ブルトン型チロシンキナーゼの阻害剤としての多環式化合物 Active JP6835846B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562265836P 2015-12-10 2015-12-10
US62/265,836 2015-12-10
PCT/US2016/065954 WO2017100662A1 (en) 2015-12-10 2016-12-09 Polycyclic compounds as inhibitors of bruton's tyrosine kinase

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021016602A Division JP7072690B2 (ja) 2015-12-10 2021-02-04 ブルトン型チロシンキナーゼの阻害剤としての多環式化合物

Publications (3)

Publication Number Publication Date
JP2018536686A JP2018536686A (ja) 2018-12-13
JP2018536686A5 true JP2018536686A5 (enExample) 2019-11-07
JP6835846B2 JP6835846B2 (ja) 2021-02-24

Family

ID=57681784

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018530000A Active JP6835846B2 (ja) 2015-12-10 2016-12-09 ブルトン型チロシンキナーゼの阻害剤としての多環式化合物
JP2021016602A Active JP7072690B2 (ja) 2015-12-10 2021-02-04 ブルトン型チロシンキナーゼの阻害剤としての多環式化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021016602A Active JP7072690B2 (ja) 2015-12-10 2021-02-04 ブルトン型チロシンキナーゼの阻害剤としての多環式化合物

Country Status (30)

Country Link
US (5) US10717745B2 (enExample)
EP (2) EP3386991B1 (enExample)
JP (2) JP6835846B2 (enExample)
KR (1) KR102103395B1 (enExample)
CN (2) CN113121562B (enExample)
AR (1) AR107042A1 (enExample)
AU (1) AU2016366541B2 (enExample)
BR (1) BR112018011526B1 (enExample)
CA (1) CA3007990C (enExample)
CY (1) CY1123263T1 (enExample)
DK (1) DK3386991T3 (enExample)
EA (1) EA035168B1 (enExample)
ES (1) ES2805835T3 (enExample)
HR (1) HRP20201193T1 (enExample)
HU (1) HUE049502T2 (enExample)
IL (1) IL259863B (enExample)
JO (1) JO3794B1 (enExample)
LT (1) LT3386991T (enExample)
MA (2) MA43409B1 (enExample)
MD (1) MD3386991T2 (enExample)
ME (1) ME03803B (enExample)
MX (1) MX387590B (enExample)
PL (1) PL3386991T3 (enExample)
PT (1) PT3386991T (enExample)
RS (1) RS60604B1 (enExample)
SI (1) SI3386991T1 (enExample)
SM (1) SMT202000404T1 (enExample)
TW (1) TWI729047B (enExample)
UY (1) UY37015A (enExample)
WO (1) WO2017100662A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3794B1 (ar) 2015-12-10 2021-01-31 Janssen Pharmaceutica Nv المركبات متعددة الحلقات كمثبطات لتيروزين كيناز بروتون
JO3793B1 (ar) * 2015-12-10 2021-01-31 Janssen Pharmaceutica Nv مثبطات تيروزين كاينيز بروتون وأساليب استخدامها
TWI795381B (zh) 2016-12-21 2023-03-11 比利時商健生藥品公司 作為malt1抑制劑之吡唑衍生物
WO2018170220A1 (en) * 2017-03-15 2018-09-20 Janssen Sciences Ireland Uc Methods of selective aryl- and heteroaryl-nitrogen bond formation
CN108164397B (zh) * 2018-01-18 2020-11-13 暨南大学 一类邻苯二酚衍生物及其制备方法
MX2020012204A (es) 2018-06-11 2021-03-31 Amgen Inc Inhibidores de kras g12c para tratar el cáncer.
KR20210151880A (ko) 2019-04-11 2021-12-14 얀센 파마슈티카 엔.브이. Malt1 억제제로서의 피리딘 고리 함유 유도체
US20230094146A1 (en) * 2020-01-07 2023-03-30 Medshine Discovery Inc. Deuterated thienopyridine compound
JP2024509828A (ja) * 2021-03-03 2024-03-05 ヤンセン ファーマシューティカ エヌ.ベー. Malt1阻害剤及びbtk阻害剤を使用する併用療法
IL308951A (en) 2021-06-04 2024-01-01 Janssen Pharmaceutica Nv Inhibitors of proton tyrosine kinase and methods of using them
CA3223610A1 (en) 2021-06-30 2023-01-05 Janssen Pharmaceutica Nv Inhibitors of bruton's tyrosine kinase and methods of their use
MX2024001840A (es) 2021-08-09 2024-02-28 Janssen Pharmaceutica Nv Composiciones para usar en el tratamiento de neoplasias de celulas b.
EP4479405A1 (en) * 2022-02-18 2024-12-25 JANSSEN Pharmaceutica NV Synthesis of bruton's tyrosine kinase inhibitors
WO2025262118A1 (en) 2024-06-20 2025-12-26 Janssen Pharmaceutica Nv Combination therapy using a malt1 inhibitor and a btk inhibitor

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3112415A1 (de) 1981-03-28 1982-10-07 Dynamit Nobel Ag, 5210 Troisdorf Verfahren zur chlorierung von cyclischen amiden und cyclischen vinylogen amiden
US5430150A (en) 1992-12-16 1995-07-04 American Cyanamid Company Retroviral protease inhibitors
US5300478A (en) 1993-01-28 1994-04-05 Zeneca Limited Substituted fused pyrazolo compounds
CN101056639A (zh) 2004-09-15 2007-10-17 詹森药业有限公司 噻唑并吡啶激酶抑制剂
WO2006118749A1 (en) * 2005-05-04 2006-11-09 Janssen Pharmaceutica, N.V. Thia-tetraazaacenaphthylene kinase inhibitors
AU2006278627B2 (en) 2005-08-08 2011-08-18 Janssen Pharmaceutica, N.V. Thiazolopyrimidine kinase inhibitors
WO2007092879A2 (en) * 2006-02-08 2007-08-16 Janssen Pharmaceutica, N.V. Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors
ES2673973T3 (es) 2006-09-22 2018-06-26 Pharmacyclics Llc Inhibidores de tirosina cinasa de Bruton
WO2010056875A1 (en) * 2008-11-12 2010-05-20 Cgi Pharmaceuticals, Inc. Pyridazinones and their use as btk inhibitors
US8486965B2 (en) 2009-08-26 2013-07-16 Takeda Pharmaceutical Company Limited Pyrrolo[2,3-b]pyridine derivative and use thereof for treatment of cancer
US9371567B2 (en) 2010-04-19 2016-06-21 The Translational Genomics Research Institute Methods and kits to predict therapeutic outcome of BTK inhibitors
FR2978441A1 (fr) 2011-07-25 2013-02-01 Diverchim Nouveaux analogues de ceramides, leurs procedes de preparation et leurs applications dans les compositions pharmaceutiques et cosmetiques
SI2970291T1 (sl) 2013-03-15 2022-07-29 Janssen Pharmaceutica, N.V. Postopki in vmesne spojine za pripravo zdravila
EA030538B1 (ru) * 2013-12-11 2018-08-31 Байоджен Ма Инк. Биарильное соединение, применяемое при лечении заболеваний человека в онкологии, неврологии и иммунологии
JO3793B1 (ar) 2015-12-10 2021-01-31 Janssen Pharmaceutica Nv مثبطات تيروزين كاينيز بروتون وأساليب استخدامها
JO3794B1 (ar) 2015-12-10 2021-01-31 Janssen Pharmaceutica Nv المركبات متعددة الحلقات كمثبطات لتيروزين كيناز بروتون
WO2018103060A1 (en) 2016-12-09 2018-06-14 Janssen Pharmaceutica Nv Inhibitors of bruton's tyrosine kinase and methods of their use
WO2018103058A1 (en) 2016-12-09 2018-06-14 Janssen Pharmaceutica Nv Inhibitors of bruton's tyrosine kinase and methods of their use

Similar Documents

Publication Publication Date Title
JP2018536686A5 (enExample)
IL259863A (en) Polycyclic compounds as inhibitors of bruton's tyrosine kinase
FI3883936T3 (fi) Uusia heterosyklisiä yhdisteitä
JP2018536684A5 (enExample)
RU2632253C2 (ru) Азотсодержащее гетероциклическое соединение или его соль
JP2019508467A5 (enExample)
RU2015113746A (ru) Замещенные сульфонамиды
JP2019521109A5 (enExample)
JP2010512337A5 (enExample)
CN114787150A (zh) 炔基喹唑啉化合物
JPWO2020012334A5 (enExample)
JP2017505794A5 (enExample)
JP2018522847A5 (enExample)
JP2019505595A5 (enExample)
RU2012152354A (ru) Производные пирролопиразина в качестве ингибиторов syk и jak
HRP20171913T1 (hr) Aminopirimidinilni spojevi kao inhibitori jak
RU2017121044A (ru) Производные амидотиадиазола в качестве ингибиторов надфн-оксидазы
RU2018131766A (ru) 6-гетероциклил-4-морфолин-4-илпиридин-2-оны, пригодные для лечения рака и диабета
JP2017511794A5 (enExample)
RU2014147191A (ru) Амидопроизводные как блокаторы ttx-s
RU2015116532A (ru) Ингибиторы тирозинкиназы syk
RU2017107521A (ru) Замещенные производные азетидина в качестве лигандов рецепторов следовых аминов taar
JP2015514679A5 (enExample)
RU2016132858A (ru) Производные фторнафтила
RU2015144385A (ru) Ациклические цианоэтилпиразолопиридоны в качестве ингибиторов янус-киназы